These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Industry progress report on neuro-oncology: Biotech update 2013. Ottenhausen M; Bodhinayake I; Banu M; Kesavabhotla K; Ray A; Boockvar JA J Neurooncol; 2013 Nov; 115(2):311-6. PubMed ID: 23949146 [TBL] [Abstract][Full Text] [Related]
3. Industry progress report on neuro-oncology: a biotech update. Haber JS; Banu MA; Ray A; Kesavabhotla K; Boockvar JA J Neurooncol; 2013 Apr; 112(2):315-21. PubMed ID: 23423513 [TBL] [Abstract][Full Text] [Related]
4. Update on glioma biotechnology. Abrams M; Reichman N; Khatri D; Patel NV; D'Amico RS; Wong T; Fralin S; Li M; Symons M; Langer D; Filippi CG; Boockvar JA Clin Neurol Neurosurg; 2020 Aug; 195():106075. PubMed ID: 32653731 [TBL] [Abstract][Full Text] [Related]
5. Financial risk of the biotech industry versus the pharmaceutical industry. Golec J; Vernon JA Appl Health Econ Health Policy; 2009; 7(3):155-65. PubMed ID: 19799470 [TBL] [Abstract][Full Text] [Related]
12. [NEURO-ONCOLOGY A NEW FIELD IN DAVIDOFF CANCER CENTER AT RABIN MEDICAL CENTER]. Yust-Katz S; Limon D; Abu-Shkara R; Siegal T Harefuah; 2017 Aug; 156(8):512-516. PubMed ID: 28853528 [TBL] [Abstract][Full Text] [Related]
13. Japan Biotech Forum: London 2010. Al-Shamahi A IDrugs; 2010 Nov; 13(11):756-8. PubMed ID: 21046519 [TBL] [Abstract][Full Text] [Related]
14. The Fourth Bioelectronic Medicine Summit "Technology Targeting Molecular Mechanisms": current progress, challenges, and charting the future. Datta-Chaudhuri T; Zanos T; Chang EH; Olofsson PS; Bickel S; Bouton C; Grande D; Rieth L; Aranow C; Bloom O; Mehta AD; Civillico G; Stevens MM; Głowacki E; Bettinger C; Schüettler M; Puleo C; Rennaker R; Mohanta S; Carnevale D; Conde SV; Bonaz B; Chernoff D; Kapa S; Berggren M; Ludwig K; Zanos S; Miller L; Weber D; Yoshor D; Steinman L; Chavan SS; Pavlov VA; Al-Abed Y; Tracey KJ Bioelectron Med; 2021 May; 7(1):7. PubMed ID: 34024277 [TBL] [Abstract][Full Text] [Related]
15. BioAsia Licensing and Deal-Making Summit-SRI Conference. Life science partnering and investment on the Pacific Rim 2-3 August, 2004, Coronado, CA, USA. Xu J IDrugs; 2004 Sep; 7(9):841-5. PubMed ID: 15470601 [TBL] [Abstract][Full Text] [Related]
16. Guidelines and policies for medical writers in the biotech industry: an update on the controversy. Foote M Biotechnol Annu Rev; 2004; 10():259-64. PubMed ID: 15504710 [TBL] [Abstract][Full Text] [Related]
17. Partnership between small biotech and big pharma. Wiederrecht GJ; Hill RG; Beer MS IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465 [TBL] [Abstract][Full Text] [Related]
18. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models. Chung TD Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951 [TBL] [Abstract][Full Text] [Related]
19. Biotech research: bringing better therapies to the people. Heinzelmann E Chimia (Aarau); 2010; 64(1-2):91-3. PubMed ID: 21137693 [TBL] [Abstract][Full Text] [Related]
20. Fourth Medical Biotech Forum of the Chinese Medical Biotech Association. 8-10 August 2009, Dalian, China. Felzmann T IDrugs; 2009 Oct; 12(10):629-32. PubMed ID: 19790012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]